Cytomegalovirus-induced thrombocytopenia and haemolysis in an immunocompetent adultVAN SPRONSEN, D. J; BREED, W. P. M.British journal of haematology. 1996, Vol 92, Num 1, pp 218-220, issn 0007-1048Article

New developments in staging and follow-up of patients with Hodgkin's lymphomaVAN SPRONSEN, D. J; VELDHUIS, G. J.Netherlands journal of medicine. 2003, Vol 61, Num 9, pp 278-284, issn 0300-2977, 7 p.Article

Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based settingVAN DE SCHANS, S. A. M; STEYERBERG, E. W; NIJZIEL, M. R et al.Annals of oncology. 2009, Vol 20, Num 10, pp 1697-1702, issn 0923-7534, 6 p.Article

Acquired angio-oedema caused by IgA paraproteinVAN SPRONSEN, D. J; HOORNTJE, S. J; HANNEMA, A. J et al.Netherlands journal of medicine. 1998, Vol 52, Num 1, pp 22-25, issn 0300-2977Article

Novel treatments for metastatic renal cell carcinomaVAN SPRONSEN, D. J; MULDERS, P. F. A; DE MULDER, P. H. M et al.Critical reviews in oncology/hematology. 2005, Vol 55, Num 3, pp 177-191, issn 1040-8428, 15 p.Article

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancerVRIENS, B. E. P. J; AARTS, M. J. B; TJAN-HEIJNEN, V. C. G et al.European journal of cancer (1990). 2013, Vol 49, Num 15, pp 3102-3110, issn 0959-8049, 9 p.Article

Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cellsVAN SPRONSEN, D. J; PEH, S. C; VRINTS, L. W et al.Histopathology. 2000, Vol 37, Num 5, pp 420-426, issn 0309-0167Article

Improved survival of Hodgkin's patients in South-East Netherlands since 1972VAN SPRONSEN, D. J; DIJKEMA, I. M; VRINTS, L. W et al.European journal of cancer (1990). 1997, Vol 33, Num 3, pp 436-441, issn 0959-8049Article

Independent prognostic effect of co-morbidity in lymphoma patients : Results of the population-based Eindhoven Cancer RegistryVAN SPRONSEN, D. J; JANSSEN-HEIJNEN, M. L. G; LEMMENS, V. E. P. P et al.European journal of cancer (1990). 2005, Vol 41, Num 7, pp 1051-1057, issn 0959-8049, 7 p.Article

Modest decline in late mortality following Hodgkin's disease in the southeastern Netherlands since 1972VAN SPRONSEN, D. J; POST, P. N; CROMMELIN, M. A et al.Annals of hematology (Print). 1998, Vol 76, Num 5, pp 205-209, issn 0939-5555Article

Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?VAN ERNING, F. N; VAN STEENBERGEN, L. N; LEMMENS, V. E. P. P et al.European journal of cancer (1990). 2014, Vol 50, Num 10, pp 1731-1739, issn 0959-8049, 9 p.Article

Treatment and complications in elderly stage III colon cancer patients in the NetherlandsHOEBEN, K. W. J; VAN STEENBERGEN, L. N; VAN DE WOUW, A. J et al.Annals of oncology. 2013, Vol 24, Num 4, pp 974-979, issn 0923-7534, 6 p.Article

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphomaVAN DE SCHANS, S. A. M; WYMENGA, A. N. M; VAN SPRONSEN, D. J et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1280-1286, issn 0923-7534, 7 p.Article

Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996VAN SPRONSEN, D. J; JANSSEN-HEIJNEN, M. L. G; BREED, W. P. M et al.Annals of hematology (Print). 1999, Vol 78, Num 7, pp 315-319, issn 0939-5555Article

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the NetherlandsJANSSEN-HEIJNEN, M. L. G; VAN STEENBERGEN, L. N; VOOGD, A. C et al.Annals of oncology. 2014, Vol 25, Num 1, pp 64-68, issn 0923-7534, 5 p.Article

Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989―2008VAN STEENBERGEN, L. N; STEUR, M; LEMMENS, V. E. P. P et al.European journal of cancer (1990). 2013, Vol 49, Num 3, pp 585-592, issn 0959-8049, 8 p.Article

Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92VAN SPRONSEN, D. J; VRINTS, L. W; HOFSTRA, G et al.British journal of haematology. 1997, Vol 96, Num 2, pp 322-327, issn 0007-1048Article

Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the NetherlandsABEN, K. K. H; HESKAMP, S; JANSSEN-HEIJNEN, M. L et al.European journal of cancer (1990). 2011, Vol 47, Num 13, pp 2023-2032, issn 0959-8049, 10 p.Article

Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemiaCUIJPERS, M. L. H; VAN SPRONSEN, D. J; MUUS, P et al.International journal of hematology. 2011, Vol 94, Num 1, pp 97-100, issn 0925-5710, 4 p.Article

No improvement in renal cell carcinoma survival : A population-based study in the NetherlandsABEN, K. K. H; LUTH, T. K; JANSSEN-HEIJNEN, M. L. G et al.European journal of cancer (1990). 2008, Vol 44, Num 12, pp 1701-1709, issn 0959-8049, 9 p.Article

Factor V inhibitor associated with cold agglutinin diseaseVAN SPRONSEN, D. J; OOSTING, J. D; HOFFMANN, J. J. M. L et al.Annals of hematology (Print). 1998, Vol 76, Num 1, pp 49-50, issn 0939-5555Article

Common variable immunodeficiency in a familyVAN SPRONSEN, D. J; KERBERT-DRETELER, M; VAN DER SLUIJS VEER, G et al.Netherlands journal of medicine. 1992, Vol 40, Num 1-2, pp 15-22, issn 0300-2977Conference Paper

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patientsLESTERHUIS, W. J; DE VRIES, Ijm; PUNT, Cja et al.British journal of cancer. 2010, Vol 103, Num 9, pp 1415-1421, issn 0007-0920, 7 p.Article